Advertisement

Obesity Surgery

, Volume 24, Issue 12, pp 2061–2068 | Cite as

Cost–Utility Analysis of Gastric Bypass for Severely Obese Patients in Spain

  • Iván Castilla
  • Javier Mar
  • Cristina Valcárcel-Nazco
  • Arantzazu Arrospide
  • Juan M. Ramos-Goñi
Original Contributions

Abstract

Background

To assess the cost–utility of gastric bypass versus usual care for patients with severe obesity in Spain.

Methods

We have implemented a discrete-event simulation model with two branches: one branch involves gastric bypass, thereby reducing patients’ BMI, and another branch where patients do not undergo surgery. The model analyzes the emergence of comorbidities (stroke, coronary obstructive disease, diabetes, and breast cancer) associated with obesity during a lifetime horizon. The selected measure of effectiveness is health-related quality of life. Both costs and effects are discounted at 3 %. A probabilistic sensitivity analysis is also performed using second-order Monte Carlo simulation; acceptability curves for different time horizons were also calculated.

Results

Patients with gastric bypass result in a lifetime increase of 5.63 quality-adjusted life years (QALYs) (18.18 vs. 12.55 QALYs). In addition, because of the reduced spending associated with the treatment of various obesity-related comorbidities, final savings stand at 13,994 €. The total cost of the intervention branch is close to half the cost of the non-intervention branch (17,431 vs. 31,425 €).

Conclusions

Gastric bypass is an intervention that dominates over the option of not intervening when a lifetime horizon is considered.

Keywords

Cost–utility Discrete-event simulation Gastric bypass 

Notes

Acknowledgments

The authors acknowledge the Spanish Ministry of Health, Social Policy and Equality for their help as a funding source.

Conflict of Interest

I. Castilla has no conflict of interest.

J. Mar has no conflict of interest.

C. Valcárcel-Nazco has no conflict of interest.

A. Arrospide has no conflict of interest.

J.M. Ramos-Goñi has no conflict of interest.

Supplementary material

11695_2014_1304_MOESM1_ESM.docx (96 kb)
ESM 1 (DOCX 96 kb)

References

  1. 1.
    Bray GA. Risks of obesity. Endocrinol. Metab. Clin. North Am. [Internet]. 2003 [cited 2012 May 22];32:787–804. Available at: http://linkinghub.elsevier.com/retrieve/pii/S0889852903000677
  2. 2.
    Overweight, obesity, and health risk. National Task Force on the Prevention and Treatment of Obesity. Arch. Intern. Med. [Internet]. 2000 [cited 2012 May 22];160:898–904. Available at: http://www.ncbi.nlm.nih.gov/pubmed/10761953
  3. 3.
    Key TJ, Allen NE, Spencer EA, et al. The effect of diet on risk of cancer. Lancet [Internet]. 2002;360:861–8. Available at: http://www.ncbi.nlm.nih.gov/pubmed/21252562
  4. 4.
    Kushner RF, Foster GD. Obesity and quality of life. Nutrition [Internet]. 2000;16:947–52. Available at: http://www.ncbi.nlm.nih.gov/pubmed/11054600
  5. 5.
    Grilo CM, Wilfley DE, Brownell KD, et al. Teasing, body image, and self-esteem in a clinical sample of obese women. Addict. Behav. [Internet]. [cited 2013 Sep 23];19:443–50. Available at: http://www.ncbi.nlm.nih.gov/pubmed/7992678
  6. 6.
    Schauer PR, Kashyap SR, Wolski K, et al. Bariatric surgery versus intensive medical therapy in obese patients with diabetes. N. Engl. J. Med. [Internet]. 2012 [cited 2012 Mar 27];120326083016000. Available at: http://www.nejm.org/doi/abs/10.1056/NEJMoa1200225
  7. 7.
    Christou N V. Impact of obesity and bariatric surgery on survival. World J. Surg. [Internet]. 2009 [cited 2012 Jul 13];33:2022–7. Available at: http://www.ncbi.nlm.nih.gov/pubmed/19440652
  8. 8.
    Sjöström L, Lindroos A-K, Peltonen M, et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N. Engl. J. Med. [Internet]. 2004 [cited 2012 Mar 2];351:2683–93. Available at: http://www.ncbi.nlm.nih.gov/pubmed/15616203
  9. 9.
    Buchwald H, Estok R, Fahrbach K, et al. Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am. J. Med. [Internet]. Elsevier Inc.; 2009 [cited 2011 Jul 4];122:248–256.e5. Available at: http://www.ncbi.nlm.nih.gov/pubmed/19272486
  10. 10.
    Buchwald H, Oien DM. Metabolic/bariatric surgery Worldwide 2008. Obes. Surg. [Internet]. 2009 [cited 2012 Mar 20];19:1605–11. Available at: http://www.ncbi.nlm.nih.gov/pubmed/19885707
  11. 11.
    Faria GR, Preto JR, Costa-Maia J. Gastric bypass is a cost-saving procedure: results from a comprehensive Markov model. Obes. Surg. [Internet]. 2013 [cited 2013 Jul 19];23:460–6. Available at: http://www.ncbi.nlm.nih.gov/pubmed/23341033
  12. 12.
    Picot J, Jones J, Colquitt JL, et al. Weight loss surgery for mild to moderate obesity: a systematic review and economic evaluation. Obes. Surg. [Internet]. 2012 [cited 2013 Jul 31];22:1496–506. Available at: http://www.ncbi.nlm.nih.gov/pubmed/22926715
  13. 13.
    Sussenbach SP, Padoin a V, Silva EN, et al. Economic benefits of bariatric surgery. Obes. Surg. [Internet]. 2012 [cited 2013 Mar 12];22:266–70. Available at: http://www.ncbi.nlm.nih.gov/pubmed/22139831
  14. 14.
    Mäklin S, Malmivaara A, Linna M, et al. Cost-utility of bariatric surgery for morbid obesity in Finland. Br. J. Surg. [Internet]. 2011 [cited 2013 Jul 19];98:1422–9. Available at: http://www.ncbi.nlm.nih.gov/pubmed/21887777
  15. 15.
    McEwen LN, Coelho RB, Baumann LM, et al. The cost, quality of life impact, and cost-utility of bariatric surgery in a managed care population. Obes. Surg. [Internet]. 2010 [cited 2012 Mar 25];20:919–28. Available at: http://www.ncbi.nlm.nih.gov/pubmed/20446053
  16. 16.
    Departamento de Sanidad. DECRETO 65/2006, de 21 de marzo. Spain: Boletín Oficial del País Vasco (BOPV); 2006 p. 6618–23.Google Scholar
  17. 17.
    Mar J, Karlsson J, Arrospide A, et al. Two-year changes in generic and obesity-specific quality of life after gastric bypass. Eat. Weight Disord. [Internet]. 2013 [cited 2013 Nov 12];18:305–10. Available at: http://www.ncbi.nlm.nih.gov/pubmed/23760910
  18. 18.
    Sjöström L, Peltonen M, Jacobson P, et al. Bariatric surgery and long-term cardiovascular events. JAMA [Internet]. 2012;307:56–65. Available at: http://www.ncbi.nlm.nih.gov/pubmed/22215166
  19. 19.
    Mingrone G, Panunzi S, De Gaetano A, et al. Bariatric surgery versus conventional medical therapy for type 2 diabetes. N. Engl. J. Med. [Internet]. 2012;366:1577–85. Available at: http://www.ncbi.nlm.nih.gov/pubmed/22449317
  20. 20.
    Instituto Nacional de Estadística (INE). Demographic phenomena [Internet]. Minist. Sanidad, Política Soc. e Igual. 2013 [cited 2013 Jul 22]. Available at: www.ine.es
  21. 21.
    Buchwald H, Estok R, Fahrbach K, et al. Trends in mortality in bariatric surgery: a systematic review and meta-analysis. Surgery [Internet]. 2007 [cited 2012 Mar 1];142:621–32; discussion 632–5. Available at: http://www.ncbi.nlm.nih.gov/pubmed/17950357
  22. 22.
    Beguiristain JM, Mar J, Arrazola A. Coste de la enfermedad cerebrovascular aguda. Rev. Neurol. [Internet]. 2005 [cited 2012 Feb 15];40:406–11. Available at: http://www.ncbi.nlm.nih.gov/pubmed/15849673
  23. 23.
    Mar J, Begiristain JM, Arrazola A. Cost-effectiveness analysis of thrombolytic treatment for stroke. Cerebrovasc. Dis. [Internet]. 2005 [cited 2012 Apr 16];20:193–200. Available at: http://www.ncbi.nlm.nih.gov/pubmed/16088115
  24. 24.
    Mata M, Antoñanzas F, Tafalla M, et al. El coste de la diabetes tipo 2 en España. El estudio CODE-2. Gac Sanit. 2002;16:511–20.PubMedCrossRefGoogle Scholar
  25. 25.
    Bertakis KD, Azari R. Obesity and the use of health care services. Obes Res. 2005;13:372–9.PubMedCrossRefGoogle Scholar
  26. 26.
    Oliva-Moreno J, Lopez-Bastida J, Worbes-Cerezo M, et al. Health related quality of life of Canary Island citizens. BMC Public Health [Internet]. 2010 [cited 2012 Apr 10];10:675. Available at: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3091580&tool=pmcentrez&rendertype=abstract
  27. 27.
    López Bastida J, Bellas Beceiro B, García Pérez L. Análisis coste-efectividad del cribado del cáncer de mama mediante mamografía en diferentes grupos de edad (40-49, 50-69 y 70-75). Madrid: Plan de Calidad para el Sistema Nacional de Salud del Ministerio de Sanidad y Política Social. Servicio de Evaluación del Servicio Canario de la Salud. Servicio de Evaluación del Servicio Canario de la Salud; 2008.Google Scholar
  28. 28.
    de Evaluación S. Encuesta de Salud de Canarias. España: Santa Cruz de Tenerife; 2009.Google Scholar
  29. 29.
    Mar J, Arrospide A, Comas M. Budget impact analysis of thrombolysis for stroke in Spain: a discrete event simulation model. Value Health [Internet]. 2010 [cited 2012 Feb 3];13:69–76. Available at: http://www.ncbi.nlm.nih.gov/pubmed/19818059
  30. 30.
    Longworth L, Buxton MJ, Sculpher M, et al. Estimating utility data from clinical indicators for patients with stable angina. Eur. J. Health Econ. [Internet]. 2005 [cited 2012 Apr 10];6:347–53. Available at: http://www.ncbi.nlm.nih.gov/pubmed/16193322
  31. 31.
    López-Bastida J, Oliva J, Antoñanzas F, et al. Spanish recommendations on economic evaluation of health technologies. Eur. J. Health Econ. [Internet]. 2010 [cited 2011 Jul 5];11:513–20. Available at: http://www.ncbi.nlm.nih.gov/pubmed/20405159
  32. 32.
    Caro JJ, Briggs AH, Siebert U, et al. modeling good research practices—overview: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force-1. Value Heal. [Internet]. 2012 [cited 2012 Sep 19];15:796–803. Available at: http://linkinghub.elsevier.com/retrieve/pii/S109830151201652X
  33. 33.
    Valencia J, Cabadés A, Ahumada M, et al. Mortalidad del infarto de miocardio en el registro PRIMVAC. Factores pronósticos Med Clin (Barc). 2004;122:561–5.CrossRefGoogle Scholar
  34. 34.
    Perry CD, Hutter MM, Smith DB, et al. Survival and changes in comorbidities after bariatric surgery. Ann. Surg. [Internet]. 2008 [cited 2012 Mar 1];247:21–7. Available at: http://www.ncbi.nlm.nih.gov/pubmed/18156918
  35. 35.
    Karlsson J, Taft C, Rydén A, et al. Ten-year trends in health-related quality of life after surgical and conventional treatment for severe obesity: the SOS intervention study. Int. J. Obes. (Lond). [Internet]. 2007 [cited 2013 Jun 20];31:1248–61. Available at: http://www.ncbi.nlm.nih.gov/pubmed/17356530
  36. 36.
    Reeves GK, Pirie K, Beral V, et al. Cancer incidence and mortality in relation to body mass index in the Million Women Study: cohort study. BMJ [Internet]. 2007 [cited 2012 Apr 1];335:1134. Available at: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2099519&tool=pmcentrez&rendertype=abstract
  37. 37.
    International Agency for Research on Cancer. Cancer Incidence, Mortality and Prevalence Worldwide in 2008 [Internet]. 2010 [cited 2012 May 10]. Available at: http://globocan.iarc.fr/
  38. 38.
    Ogden J, Clementi C. The experience of being obese and the many consequences of stigma. J. Obes. [Internet]. 2010 [cited 2013 Jul 19];2010. Available at: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2915811&tool=pmcentrez&rendertype=abstract
  39. 39.
    Sprangers MA, Van Dam FS, Broersen J, et al. Revealing response shift in longitudinal research on fatigue—the use of the then–test approach. Acta Oncol. [Internet]. 1999;38:709–18. Available at: http://www.ncbi.nlm.nih.gov/pubmed/10522761
  40. 40.
    Suter M, Donadini A, Romy S, et al. Laparoscopic roux-en-y gastric bypass: significant long-term weight loss, improvement of obesity-related comorbidities and quality of life. Ann. Surg. [Internet]. 2011 [cited 2012 Mar 1];254:267–73. Available at: http://www.ncbi.nlm.nih.gov/pubmed/21772127
  41. 41.
    Hankey G. Stroke Treatment and prevention: an evidence-based approach. 1st ed. New York: Cambridge University Press; 2009. p. 536.Google Scholar
  42. 42.
    Soriguer F, Goday A, Bosch-Comas A, et al. Prevalence of diabetes mellitus and impaired glucose regulation in Spain: the Di@bet.es Study. Diabetologia [Internet]. 2012 [cited 2012 Mar 6];55:88–93. Available at: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3228950&tool=pmcentrez&rendertype=abstract
  43. 43.
    Lloyd-Jones DM, Larson MG, Beiser A, et al. Lifetime risk of developing coronary heart disease. Lancet [Internet]. 1999 [cited 2011 Oct 7];353:89–92. Available at: http://www.ncbi.nlm.nih.gov/pubmed/10094006
  44. 44.
    Seshadri S, Wolf PA. Lifetime risk of stroke and dementia: current concepts, and estimates from the Framingham Study. Lancet Neurol. [Internet]. 2007 [cited 2013 Jul 22];6:1106–14. Available at: http://www.ncbi.nlm.nih.gov/pubmed/18031707
  45. 45.
    Gloeckler Ries LA, Reichman ME, Lewis DR, et al. Cancer survival and incidence from the Surveillance, Epidemiology, and End Results (SEER) program. Oncologist [Internet]. 2003 [cited 2013 Jul 22];8:541–52. Available at: http://www.ncbi.nlm.nih.gov/pubmed/14657533
  46. 46.
    Paap E, Broeders MJM, van Schoor G, Otten JDM, Verbeek ALM. Large increase in a Dutch woman’s lifetime risk of developing breast cancer. Eur. J. Cancer [Internet]. 2008 [cited 2013 Jul 22];44:1485–7. Available at: http://www.ncbi.nlm.nih.gov/pubmed/18479909

Copyright information

© Springer Science+Business Media New York 2014

Authors and Affiliations

  • Iván Castilla
    • 1
    • 2
    • 5
  • Javier Mar
    • 3
    • 4
  • Cristina Valcárcel-Nazco
    • 2
    • 5
  • Arantzazu Arrospide
    • 3
    • 4
  • Juan M. Ramos-Goñi
    • 1
    • 6
  1. 1.Health Services Research on Chronic Patients Network (REDISSEC)Santa Cruz de TenerifeSpain
  2. 2.Centre for Biomedical Research of the Canary IslandsUniversidad de La LagunaLa LagunaSpain
  3. 3.Health Services Research on Chronic Patients Network (REDISSEC)Santa Cruz de TenerifeSpain
  4. 4.Clinical Management ServiceAlto Deba HospitalMondragonSpain
  5. 5.Canary Islands Foundation for Health and Research (FUNCIS)Santa Cruz de TenerifeSpain
  6. 6.HTA Unit of the Canary Islands Health Service (SESCS)Santa Cruz de TenerifeSpain

Personalised recommendations